NCT05884463View on ClinicalTrials.gov

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

February 28, 2023

Study Completion Date

February 28, 2023

Conditions
18F-FAPI18F-FDGPancreas AdenocarcinomaDiagnosisStaging
Interventions
DRUG

18F-FAPI

Intravenous injection of one dosage of 18F-FAPI.

DRUG

18F-FDG

Intravenous injection of one dosage of 18F-FDG.

Trial Locations (1)

310003

the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Zhejiang University

OTHER

NCT05884463 - 18F-FAPI PET Imaging in Pancreatic Adenocarcinoma | Biotech Hunter | Biotech Hunter